Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jan 23;13(1):e062322.
doi: 10.1136/bmjopen-2022-062322.

Efficacy and safety of hyperbaric oxygen therapy for fibromyalgia: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Efficacy and safety of hyperbaric oxygen therapy for fibromyalgia: a systematic review and meta-analysis

Xinxin Chen et al. BMJ Open. .

Abstract

Objective: To investigate the efficacy and safety of hyperbaric oxygen therapy (HBOT) for fibromyalgia (FM).

Design: A systematic review and meta-analysis.

Data sources: PubMed, EMBASE, Cochrane Library, Web of Science, VIP (China Science and Technology Journal Database), CNKI (China National Knowledge Infrastructure) and WanFang database were searched from from inception to 22 October 2022.

Eligibility criteria: We included clinical trials (randomised controlled and non-randomised controlled trials) of HBOT for FM.

Data extraction and synthesis: Two researchers independently screened the literature, extracted data and evaluated the quality of the included studies, with disagreements resolved by a third researcher. The Cochrane Collaboration checklists and the Methodological Index for Non-randomised Studies were used to assess the risk of bias. Meta-analysis was performed by RevMan V.5.4.1 software. Random effect models were used for meta-analysis.

Results: Nine studies were included in this review, with a total of 288 patients. For pain assessment, we combined the results of the Visual Analogue Scale and Widespread Pain Index. The results showed that HBOT could relieve the pain of FM patients compared with the control intervention (standardised mean difference=-1.56, 95% CI (-2.18 to -0.93), p<0.001, I 2=51%). Most included studies reported that HBOT ameliorated tender points, fatigue, multidimensional function, patient global and sleep disturbance in FM. Adverse events occurred in 44 of 185 patients (23.8%). Twelve patients (6.5%) withdrew because of adverse reactions. No serious adverse events or complications were observed.

Conclusions: HBOT might have a positive effect in improving pain, tender points, fatigue, multidimensional function, patient global and sleep disturbance in FM, with reversible side effects. Low pressure (less than 2.0 atmospheric absolute) may be beneficial to reduce adverse events in FM. Further studies should be carried out to evaluate the optimal protocol of HBOT in FM.

Prospero registration number: CRD42021282920.

Keywords: PAIN MANAGEMENT; Rehabilitation medicine; Rheumatology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
PRISMA flow chart. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Figure 2
Figure 2
Risk of bias graph for the included randomised controlled trials across five domains. The red circle indicates a high risk of bias within that domain for a given study, the yellow circles indicate an unclear risk of bias and the green circles indicate a low risk of bias.
Figure 3
Figure 3
Forest plot of pain relief. HBOT, hyperbaric oxygen therapy.

Similar articles

Cited by

References

    1. Sueiro Blanco F, Estévez Schwarz I, Ayán C, et al. . Potential benefits of non-pharmacological therapies in fibromyalgia. Open Rheumatol J 2008;2:1–6. 10.2174/1874312900802010001. - DOI - PMC - PubMed
    1. Thomas EN, Blotman F. Aerobic exercise in fibromyalgia: a practical review. Rheumatol Int 2010;30:1143–50. 10.1007/s00296-010-1369-6. - DOI - PubMed
    1. Alciati A, Nucera V, Masala IF, et al. . One year in review 2021: fibromyalgia. Clin Exp Rheumatol 2021;39 Suppl 130:3–12. 10.55563/clinexprheumatol/gz4i3i. - DOI - PubMed
    1. Siracusa R, Paola RD, Cuzzocrea S, et al. . Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci 2021;22:3891. 10.3390/ijms22083891. - DOI - PMC - PubMed
    1. Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol 2011;7:518–27. 10.1038/nrrheum.2011.98. - DOI - PubMed

Publication types